Methods and Compositions for use in Gene Therapy for Treatment of Hemophilia

摘要

Provided are compositions of viruses, the viruses including a recombinant adeno-associated virus vector comprising at least two adeno-associated virus inverted terminal repeats, a promoter/regulatory sequence, isolated DNA encoding a blood coagulation factor and accompanying 5′and 3′untranslated regions and a transcription termination sequence.